To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study
NA
To evaluate the safety and efficacy of pegylated liposomal doxorubicin/cycl...
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
PHASE3
In this open-label multicenter trial, participants with operable or locally...
Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.
PHASE3
This is a multicenter, randomized, double-blind, parallel-controlled Phase ...
Status
Unknown
Location
The First Affiliated Hospital of Chongqing Medical University